Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login
  • Users Online: 37
  • Home
  • Print this page
  • Email this page

Asia-Pacific Journal of Oncology Nursing (APJON, ISSN 2347-5625, eISSN 2349-6673) is the official journal of Asian Oncology Nursing Society. APJON is a peer-reviewed, open access journal. The journal is now indexed in Scopus, PubMed, SCIE, and SSCI.

APJON is a Bimonthly issue which addresses different spectrums in relation to oncology nursing for cancer patients--prevention, screening and early detection, geriatric and pediatric cancer nursing, medical and surgical oncology, ambulatory care, nutritional support, cancer related psychosocial issues and support, management of cancer symptom and side effects caused by different types of cancer treatment, palliative care and end of life care, long term survivorship and other issues and care related to cancer patients, especially nursing innovations and the research findings in these areas.

The journal covers different and up-to-date information which is divided into AONS news, editorial, review, original article, case report, letter to editor, short report, technical notes, nurse education, etc. In particular, APJON will serve as a platform for all oncology nurses from Asia Pacific region to share information in each field of oncology nursing.

ICCN 2022
APJON-IF-Banner
APJON-IF-Banner
Indexed in PubMed

Current Issue

November-December 2021| Vol 8| Issue 6

Editorial

Single-Cell Landscape of Liver Cancer in Response to Immunotherapy

Primary liver cancer is the sixth most commonly diagnosed cancer in the world, with 905,677 new cases of liver cancer in 2020, and the third leading cause of cancer death globally.[1] The liver canc...


Editorial

MET Inhibitor is Expected to Overcome MET Amplification-Induced Immunotherapy Resistance in Non-Small Cell Lung Cancer

In 2018, lung cancer occurred in 2.09 million people and resulted in 1.76 million deaths worldwide.[1],[2] It imposes a great disease burden on patients in China with a rapidly increasing trend duri...


Review Article

Follow-up Care for Patients Receiving Immune Checkpoint Inhibitors

The rapid advances in cancer immunotherapy using immune checkpoint inhibitors (ICIs) have led to significantly improved survival of patients. But at the same time, it also associates with multiple i...


Review Article

Oral Immune-Related Adverse Events – Current Concepts and their Management

Recent advent of immune checkpoint inhibitors (ICIs) have made significant improvement in the treatment outcome of cancer patients. They are also known to increase the overall survival in many malig...


Abstracting and Indexing Information

The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), Current Contents/Clinical Medicine , EBSCO Publishing's Electronic Databases, Ex Libris Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TDNet, Wanfang Data

The journal is indexed with, or included in, the following:
DOAJ, PubMed Central, SCOPUS, Science Citation Index Expanded, Social Sciences Citation Index

Impact Factor as reported in the 2020 Journal Citation Reports (Clarivate Analytics, 2021): 2.509

APJON Features

  • Online submission
  • Wider visibility through open access
  • Higher impact with wider visibility
  • Prompt review
  • Driven by international, well-known nursing experts
  • APJON is indexed in Scopus, PubMed, SCIE and SSCI
  • APJON supports "Publish Ahead of Print"
Submit Article Subscribe Most Popular Articles Join as Reviewer Email Alerts Recommend this journal to your library or friends